Henry T. Lynch

Henry T. Lynch
Born(1928-01-04)January 4, 1928
Lawrence, Massachusetts, U.S.
DiedJune 2, 2019(2019-06-02) (aged 91)
Omaha, Nebraska, U.S.
Alma mater
OccupationPhysician
Known forDiscovery of genetic causes of cancer and namesake of Lynch syndrome

Henry Thompson Lynch (January 4, 1928 – June 2, 2019) was an American physician noted for his discovery of familial susceptibility to certain kinds of cancer and his research into genetic links to cancer.

He is sometimes described as "the father of hereditary cancer detection and prevention"[1] or the "father of cancer genetics",[2] although Lynch himself said that title should go to the early 20th century pathologist Aldred Scott Warthin.[3]

Lynch was the chairman of preventive medicine at Creighton University School of Medicine in Omaha, Nebraska and held the Charles F. and Mary C. Heider Endowed Chair in Cancer Research.

  1. ^ "Lynch Syndrome: An Interview With the Father of Hereditary Cancer Detection and Prevention, Henry T. Lynch, MD". Interview with the Innovators. The Oncology Pharmacist. March 2013. Archived from the original on 28 December 2018. Retrieved 25 November 2013.
  2. ^ "Henry T. Lynch, M.D." North Shore University Health System. Retrieved 25 November 2013.
  3. ^ Robertson, Erle S., ed. (2012). "1. Peyton Rous". Cancer Associated Viruses. Springer. p. 5. ISBN 978-1-4614-0016-5.